Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007004226) COMPOSITIONS AND METHODS FOR TREATMENT OF MALE ERECTILE DYSFUNCTION (ED)
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/004226 International Application No.: PCT/IL2006/000778
Publication Date: 11.01.2007 International Filing Date: 05.07.2006
IPC:
A61K 31/35 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
Applicants:
DARLEY PHARMACUETICALS LTD. [IL/IL]; P.o. Box 3096 38900 Caesarea Industrial Park, IL (AllExceptUS)
MUSAFIA, Boaz [IL/IL]; IL (UsOnly)
ZAMIR, Deganit [IL/IL]; IL (UsOnly)
Inventors:
MUSAFIA, Boaz; IL
ZAMIR, Deganit; IL
ZAMIR, Nadav; null
Agent:
WEBB, Cynthia ; WEBB & ASSOCIATES P.o. Box 2189 76121 Rehovot, IL
Priority Data:
60/695,87005.07.2005US
Title (EN) COMPOSITIONS AND METHODS FOR TREATMENT OF MALE ERECTILE DYSFUNCTION (ED)
(FR) COMPOSITIONS ET PROCEDES POUR LE TRAITEMENT DE DYSFONCTIONNEMENT DE L'ERECTION
Abstract:
(EN) The present invention relates to use of 1,7-dioxaspiro[5.5]undecane and related compounds of the general formula (I) for the preparation of a pharmaceutical composition for the treatment or prevention of erectile dysfunction (ED). The invention further provides a method for the treatment or prevention of ED by administering 1,7-dioxaspiro[5.5]undecane or a related compound of the general formula (I) as an active ingredient, thereby treating and/or preventing ED.
(FR) Utilisation de 1,7-dioxaspiro[5.5]undécane et de composés connexes de formule générale (I) pour l'élaboration de composition pharmaceutique intervenant dans le traitement ou la prévention de dysfonctionnement de l'érection, et procédés correspondants qui reposent sur l'administration de 1,7dioxaspiro[5.5]undécane ou de composé connexe de formule générale (I) comme principe actif, pour le traitement et/ou la prévention de l'affection considérée..
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)